MAVS
Mitochondrial antiviral-signaling protein · Q7Z434 · MAVS on Sugi Atlas →
0 patent compounds predicted against MAVS, 0 high-confidence (nearest known ligand ≥ 0.5)
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to MAVS by text similarity (a relevance ranking, not an exhaustive list)
Related proteins — ESM-2 sequence neighbours (a MAVS binder may also engage these)
| Protein | Name | Similarity | |
|---|---|---|---|
| Q66HG9 | — | 0.996 | Q66HG9 → |
| Q8N1P7 | — | 0.992 | Q8N1P7 → |
| Q6NXZ1 | — | 0.992 | Q6NXZ1 → |
| Q7TSA6 | — | 0.990 | Q7TSA6 → |
| Q8VCF0 | — | 0.990 | Q8VCF0 → |
| Q0GGX2 | — | 0.990 | Q0GGX2 → |
| Q6DIA7 | — | 0.990 | Q6DIA7 → |
| E9Q394 | — | 0.989 | E9Q394 → |
| Q5VV67 | — | 0.989 | Q5VV67 → |
| Q8BHE4 | — | 0.989 | Q8BHE4 → |
| Q5DTX6 | — | 0.989 | Q5DTX6 → |
| E9Q286 | — | 0.989 | E9Q286 → |
| Q8BWS5 | — | 0.989 | Q8BWS5 → |
| B7ZNG4 | — | 0.988 | B7ZNG4 → |
| A6QLF8 | — | 0.988 | A6QLF8 → |
| Q96L96 | — | 0.988 | Q96L96 → |
| Q12815 | — | 0.988 | Q12815 → |
| Q8N944 | — | 0.988 | Q8N944 → |
| Q6NS69 | — | 0.987 | Q6NS69 → |
| Q4R736 | — | 0.987 | Q4R736 → |
| A6NFR6 | — | 0.987 | A6NFR6 → |
| Q924C5 | — | 0.987 | Q924C5 → |
| Q71M36 | — | 0.987 | Q71M36 → |
| Q3UIZ8 | — | 0.987 | Q3UIZ8 → |
| Q5RCQ2 | — | 0.986 | Q5RCQ2 → |
| D3ZUE1 | — | 0.986 | D3ZUE1 → |
| Q5SWP3 | — | 0.986 | Q5SWP3 → |
| Q8BHP2 | — | 0.986 | Q8BHP2 → |
| Q6PAC4 | — | 0.986 | Q6PAC4 → |
| A8MYA2 | — | 0.986 | A8MYA2 → |